Download the Free Prime PubMed App to your smartphone or tablet.

Available for iPhone or iPad:

Unbound PubMed app for iOS iPhone iPadAlso Available:
Unbound MEDLINE
Unbound PubMed app for Android

Available for Mac and Windows Desktops and laptops:

Unbound PubMed app for Windows
(Qsymia 7 5 46)
2 results
  • Cost-Effectiveness Analysis of Qsymia for Weight Loss. [Journal Article]
    Pharmacoeconomics 2015; 33(7):699-706Finkelstein EA, Kruger E, Karnawat S
  • CONCLUSIONS: Although base-case results suggest that Qsymia is cost-effective, this result hinges on the time on Qsymia and the extent to which benefits are maintained post medication cessation. This should be an area of future research.
  • Phentermine/topiramate for the treatment of obesity. [Review]
    Ann Pharmacother 2013; 47(3):340-9Smith SM, Meyer M, Trinkley KE
  • CONCLUSIONS: PHEN/TPM is a new, once-daily, controlled-release, combination weight-loss product approved as an adjunct to diet and exercise for chronic weight management of obese or overweight patients with weight-related comorbidities. PHEN/TPM is modestly effective and a viable option for patients interested in losing weight, although long-term safety data are lacking.
New Search